Effective coverage for hypertension treatment among middle-aged adults and the older population in China, 2011 to 2013: A nationwide longitudinal study

J Glob Health. 2020 Jun;10(1):010805. doi: 10.7189/jogh.10.010805.

Abstract

Methods: We used the baseline survey and first follow-up surveys of the China Health and Retirement Longitudinal Study of middle-aged and older populations conducted between 2011 and 2013. Correlates of effective coverage and treatment coverage for hypertension were analysed using multivariate logistic regression models, after controlling for demographic characteristics.

Results: In 2011, 38.40% of 13 702 individuals surveyed were identified with hypertension. Overall, the effective treatment coverage among the middle-aged and older population in China from 2011 to 2013 was only 22.40% compared to the treatment coverage of 55.86%. Variations in effective coverage among patients enrolled in the three public health insurance schemes ranged from 22.60% to 29.31%.

Conclusions: The level of effective coverage for hypertension treatment in China was still very low, and that health insurance schemes play a significant role in improving treatment coverage and effective coverage for hypertension treatment. In the implementation of China's health system reform, health equity and health care equality should be emphasised and enhanced by offering more equitable benefits packages across social health insurance schemes.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antihypertensive Agents / economics
  • Antihypertensive Agents / therapeutic use*
  • China / epidemiology
  • Female
  • Health Care Reform
  • Health Expenditures / statistics & numerical data*
  • Health Services / statistics & numerical data*
  • Health Services Accessibility / statistics & numerical data
  • Healthcare Disparities
  • Healthy Aging
  • Humans
  • Hypertension / drug therapy*
  • Hypertension / epidemiology
  • Insurance Coverage / statistics & numerical data*
  • Insurance, Health / statistics & numerical data*
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Retirement
  • Universal Health Insurance / economics

Substances

  • Antihypertensive Agents